
Market revenue from type 2 diabetes pharmaceuticals by region 2012-2022
This statistic displays the regional distribution of global type 2 diabetes pharmaceutical market revenues in 2012 and 2022. In 2012, the United States' type 2 diabetes pharmaceutical market accumulated 18.4 billion U.S. dollars in revenues. The market for type 2 diabetes is emerging and is expected to grow as the prevalence of diabetes increases in China, India, and Brazil.